D. Flavell

发表

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes.

P. Talmud, J. Ansquer, J. Kastelein, 2004, Pharmacogenetics.

Variation in the promoter of the human hormone sensitive lipase gene shows gender specific effects on insulin and lipid levels: results from the Ely study.

P. Talmud, N. Wareham, D. Waterworth, 2001, Biochimica et biophysica acta.

Dominant dwarfism in transgenic rats by targeting human growth hormone (GH) expression to hypothalamic GH‐releasing factor neurons.

I. Robinson, D. Carmignac, T. Wells, 1996, The EMBO journal.

Interactions between neuropeptide Y and growth hormone receptor gene transcripts in the arcuate nucleus

S. Lightman, D. Flavell, A. Levy, 1996 .

Effects of growth hormone secretagogues in the transgenic growth-retarded (Tgr) rat.

I. Robinson, D. Carmignac, T. Wells, 1997, Endocrinology.

Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

S. Humphries, E. Hawe, Y. Jamshidi, 2002, Atherosclerosis.

Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.

C. V. D. van der Kallen, P. Eurlings, J. Geurts, 2002, Molecular genetics and metabolism.

Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes.

S. Humphries, E. Hawe, J. Stephens, 2005, Diabetes.

Variation in the lipoprotein lipase gene influences exercise-induced left ventricular growth

P. Talmud, D. Pennell, S. Myerson, 2006, Journal of Molecular Medicine.

Peroxisome Proliferator–Activated Receptor &agr; Gene Regulates Left Ventricular Growth in Response to Exercise and Hypertension

H. Hense, J. Erdmann, C. Hengstenberg, 2002, Circulation.

Peroxisome Proliferator-Activated Receptor (cid:1) Gene Variants Influence Progression of Coronary Atherosclerosis and Risk of Coronary Artery Disease

M. Nieminen, E. Hawe, P. Talmud, 2002 .

Response to Exercise and Hypertension Gene Regulates Left Ventricular Growth in α Activated Receptor − Peroxisome Proliferator

H. Hense, J. Erdmann, C. Hengstenberg, 2002 .

IP receptor-dependent activation of PPARγ by stable prostacyclin analogues

B. Staels, A. Tinker, S. Haworth, 2007, Biochemical and biophysical research communications.

Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat.

I. Robinson, D. Carmignac, B. Gabrielsson, 1995, Endocrinology.

PPARα gene variation and physical performance in Russian athletes

D. Popov, B. Shenkman, H. Montgomery, 2006, European Journal of Applied Physiology.

High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both α and γ interferons

I. Kerr, J. John, G. Stark, 1991 .

The structure of a human neurofilament gene (NF-L): a unique exon-intron organization in the intermediate filament gene family.

F. Grosveld, J. Julien, D. Flavell, 1987, Biochimica et biophysica acta.

Haplotype analysis of the PPARγ Pro12Ala and C1431T variants reveals opposing associations with body weight

A. Morris, A. Doney, C. Palmer, 2002, BMC Genetics.

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

P. Talmud, Y. Jamshidi, B. Staels, 2000, Diabetologia.

Transcriptional and post-transcriptional effects of nerve growth factor on expression of the three neurofilament subunits in PC-12 cells.

F. Grosveld, S. Carbonetto, M. Lindenbaum, 1988, The Journal of biological chemistry.

Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

D. Tregouet, P. Talmud, N. Tahri-Daizadeh, 2004, Human molecular genetics.

High-frequency mutagenesis of human cells and characterization of a mutant unresponsive to both alpha and gamma interferons.

G. Stark, I. Kerr, J. John, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Isolation and characterization of a new mutant human cell line unresponsive to alpha and beta interferons

G. Stark, I. Kerr, J. John, 1991, Molecular and cellular biology.

Variants in the APOC3 promoter insulin responsive element modulate insulin secretion and lipids in middle-aged men.

N. Wareham, D. Waterworth, J. Luan, 2003, Biochimica et biophysica acta.

Cloning and developmental expression of the murine neurofilament gene family.

F. Grosveld, J. Hurst, J. Julien, 1986, Brain research.

Characterization of the Human PPAR Promoter : Identification of a Functional Nuclear Receptor Response Element

Y. Jamshidi, B. Staels, J. Fruchart, 2002 .

Progression of Atherosclerosis Is Associated With Variation in the &agr;1-Antitrypsin Gene

M. Nieminen, S. Humphries, P. Talmud, 2003, Arteriosclerosis, thrombosis, and vascular biology.

Peroxisome Proliferator-Activated Receptor α Gene Variation Influences Age of Onset and Progression of Type 2 Diabetes

S. Humphries, E. Hawe, J. Stephens, 2005 .

Sequence and structure of the mouse gene coding for the largest neurofilament subunit.

F. Grosveld, J. Julien, Malak Sidky, 1988, Gene.

Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease.

M. Nieminen, E. Hawe, P. Talmud, 2002, Circulation.

Coronary Atherosclerosis and Risk of Coronary Artery Disease Gene Variants Influence Progression of α Peroxisome Proliferator-Activated Receptor

M. Nieminen, E. Hawe, P. Talmud, 2002 .

The human neurofilament gene (NEFL) is located on the short arm of chromosome 8.

F. Grosveld, J. Hurst, J. Julien, 1987, Cytogenetics and cell genetics.

The lipoprotein lipase gene serine 447 stop variant influences hypertension-induced left ventricular hypertrophy and risk of coronary heart disease.

A. Balmforth, A. Hall, P. Talmud, 2007, Clinical science.

Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene.

G. Stark, I. Kerr, G. Foster, 1991, Nucleic acids research.

Lipoprotein-associated phospholipase A2 A379V variant is associated with body composition changes in response to exercise training.

P. Talmud, H. Montgomery, M. World, 2007, Nutrition, metabolism, and cardiovascular diseases : NMCD.

A novel functional polymorphism in the PECAM-1 gene (53G>A) is associated with progression of atherosclerosis in the LOCAT and REGRESS studies.

A. Zwinderman, M. Nieminen, S. Humphries, 2003, Atherosclerosis.

Visceral obesity without insulin resistance in late-onset obesity rats.

I. Robinson, P. L. Le Tissier, R. K. Bains, 2004, Endocrinology.

Transgenesis and neuroendocrine physiology: a transgenic rat model expressing growth hormone in vasopressin neurones

I. Robinson, H. Christian, D. Flavell, 2003, The Journal of physiology.

PPARalpha gene variation and physical performance in Russian athletes.

D. Popov, B. Shenkman, H. Montgomery, 2006, European journal of applied physiology.

Pituitary growth hormone-releasing factor receptor expression in normal and dwarf rats.

I. Robinson, D. Carmignac, D. Flavell, 1996, Neuroendocrinology.

Isolation andCharacterization ofaNew MutantHumanCellLine Unresponsive toAlphaandBetaInterferons

S. Pellegrini, D. Flavell, 1991 .

Cloning and developmental expression of the murine neurofilament gene family.

F. Grosveld, J. Hurst, J. Julien, 1986, Brain research.